Please note, this event is planned and hosted by the Cornell University College of Engineering. The Cornell Club of Boston is not involved with this event.
With the development of smarter medical devices and more effective novel therapies, convergent technologies are fast becoming the future of biotech. In response to this changing trend, Cornell is strengthening its emphasis on the convergence of its academic disciplines. Currently, interdisciplinary research is at its strongest point in Cornell's history, with relationships growing across all university units and beyond, including Engineering, the College of Veterinary Medicine, Weill Cornell Medical Center, and Cornell's long-time partner, Hospital for Special Surgery.
Please join us for an inspiring evening, as we chart the future of the industry, and explore the groundbreaking work Cornell is doing at the interface of biology, medicine, and engineering.
Dr. Lance Collins
Joseph Silbert Dean of Engineering, Cornell College of Engineering
Dr. Robert Langer, BS Engineering 1970
David H. Koch Institute Professor, MIT,
2015 Cornell Entrepreneur of the Year,
2015 Queen Elizabeth Prize for Engineering Award Recipient
Followed by a roundtable discussion led by Dr. Langer, with:
Dr. Christopher Alabi
Nancy and Peter Meinig Family Investigator in the Life Sciences
Dr. Michelle Delco, BS '98, DVM '02
Staff Surgeon, Cornell College of Veterinary Medicine
Dr. Marjolein van der Meulen
James M. and Marsha McCormick Chair of Biomedical Engineering, Swanson Professor of Biomedical Engineering in the Department of Biomedical Engineering and the Sibley School of Mechanical and Aerospace Engineering at Cornell University & Senior Scientist in the Research Division of the Hospital for Special Surgery
Monday, March 2, 2015
- 5:45 p.m. Reception
- 6:30 p.m. Program
Genzyme Center Corporate Headquarters, 500 Kendall Street, Cambridge, MA
$25 per person
Please contact Anthony Escobar at email@example.com with any questions about this event.